Reciprocal activating interaction between natural killer cells and dendritic cells. - Wikidata - awgldk - TriplyDB

Reciprocal activating interaction between natural killer cells and dendritic cells.

Reciprocal activating interaction between natural killer cells and dendritic cells.

http://www.wikidata.org/entity/Q41992239

about

Natural selection of tumor variants in the generation of "tumor escape" phenotypes Transforming growth factor beta 1 inhibits expression of NKp30 and NKG2D receptors: consequences for the NK-mediated killing of dendritic cells Natural killer cells and autoimmunity Dendritic Cells: A Double-Edged Sword in Immune Responses during Chagas Disease Recognition and Regulation of T Cells by NK Cells Pleiotropic Effects of IL-2 on Cancer: Its Role in Cervical Cancer Crosstalk between innate and adaptive immunity in hepatitis B virus infection Natural Killer Cell Recognition of Melanoma: New Clues for a More Effective Immunotherapy Dendritic Cells in Oncolytic Virus-Based Anti-Cancer Therapy Virological Mechanisms in the Coinfection between HIV and HCV Reciprocal crosstalk between dendritic cells and natural killer cells under the effects of PGE2 in immunity and immunopathology Current perspectives on natural killer cell education and tolerance: emerging roles for inhibitory receptors Tumor antigen-specific monoclonal antibodies and induction of T-cell immunity Dendritic Cells in HIV-1 and HCV Infection: Can They Help Win the Battle?The immunobiology of prostanoid receptor signaling in connecting innate and adaptive immunity Plasmacytoid dendritic cells and type I IFN: 50 years of convergent history Human NK Cell Subsets Redistribution in Pathological Conditions: A Role for CCR7 Receptor Insufficient natural killer cell responses against retroviruses: how to improve NK cell killing of retrovirus-infected cells Boosting vaccine efficacy the natural (killer) way A one year follow-up study of natural killer and dendritic cells activities in multiple sclerosis patients receiving glatiramer acetate (GA)Identification of a polyI:C-inducible membrane protein that participates in dendritic cell-mediated natural killer cell activation Modeling leukocyte-leukocyte non-contact interactions in a lymph node Interleukin-12 secreted by mature dendritic cells mediates activation of NK cell function Natural killer cell differentiation driven by Tyro3 receptor tyrosine kinases HemaMax™, a recombinant human interleukin-12, is a potent mitigator of acute radiation injury in mice and non-human primates Natural killer cells regulate Th1/Treg and Th17/Treg balance in chlamydial lung infection A LysM and SH3-domain containing region of the Listeria monocytogenes p60 protein stimulates accessory cells to promote activation of host NK cells.Human dendritic cells adenovirally-engineered to express three defined tumor antigens promote broad adaptive and innate immunity.Self MHC class I-licensed NK cells enhance adaptive CD8 T-cell viral immunity.MHC class I D(k) expression in hematopoietic and nonhematopoietic cells confers natural killer cell resistance to murine cytomegalovirus Natural killer cells actively patrol peripheral lymph nodes forming stable conjugates to eliminate MHC-mismatched targets.Failed CTL/NK cell killing and cytokine hypersecretion are directly linked through prolonged synapse time.Cross-talk with myeloid accessory cells regulates human natural killer cell interferon-gamma responses to malaria.Randomized comparison of single dose of recombinant human IL-12 versus placebo for restoration of hematopoiesis and improved survival in rhesus monkeys exposed to lethal radiation.Heat shock protein vaccination and directed IL-2 therapy amplify tumor immunity rapidly following bone marrow transplantation in mice.Distinct and complementary functions of MDA5 and TLR3 in poly(I:C)-mediated activation of mouse NK cells.Blocking NK cell inhibitory self-recognition promotes antibody-dependent cellular cytotoxicity in a model of anti-lymphoma therapy.The peptide sequence of diacyl lipopeptides determines dendritic cell TLR2-mediated NK activation.Chimeric Antigen Receptor-Engineered NK-92 Cells: An Off-the-Shelf Cellular Therapeutic for Targeted Elimination of Cancer Cells and Induction of Protective Antitumor Immunity Therapeutic and tumor-specific immunity induced by combination of dendritic cells and oncolytic adenovirus expressing IL-12 and 4-1BBL.

P2860

Q24551158-E0D4C5FF-9A64-4EB0-961C-DC8D00B6A189 Q24683311-732DA863-38B4-43D8-AFC3-80DA8423470C Q24793284-65BF1A88-BC07-4AED-BEE1-43CFF7A6A89E Q26740647-99595F4D-D937-41D0-ABC5-68EAD5B709D3 Q26742166-0B18EAAA-338D-4FFF-97A2-DF943B768C86 Q26747008-44FEF800-C0F7-4192-A022-E353DEFABCE1 Q26771142-83FE53C0-D2D5-4AA5-9A3B-550DAA5B51E7 Q26771449-E73602A3-FACE-4DCD-AA53-B90F726B6086 Q26774345-67397DB5-779D-45AA-80DA-71C4B7C9A64D Q26780313-158E5796-7B39-42DB-BCD7-1E0ABFCE02DA Q26825075-E6852F5C-F912-434F-87E8-F5E24268CF55 Q27009135-41990945-9A68-4470-891E-B8035F05E5A0 Q27009908-02817095-EFB0-491B-926B-D1E2372846CB Q27010312-7E0ED9E5-3D16-46AF-BB60-5E7B7647B0C4 Q27021651-3D9C2C88-E2F1-4FAF-947D-AED4466FBF9D Q27485637-5F95621F-7338-487D-8A84-717634463E64 Q28067468-91213EA1-99B0-4E40-94DA-0851D149F693 Q28068375-CA01FB31-CD02-444E-861D-F22F4972F74D Q28084474-58AE3FE2-733C-46CB-B50F-41996F76FB27 Q28486389-9C112599-0734-417D-BC0E-11F2B874B691 Q28508164-D39C97C5-3996-4A51-9853-B5CCE36F8963 Q28534660-511A36B3-04C9-44BD-9D19-080B02DFDE17 Q28569690-D6DF7868-0BCB-4B8A-B337-A32CFA26922D Q28587024-8D39D75F-39C3-4DBD-9398-46EF9D352CD2 Q28731776-522B328A-2D4D-4A01-BCE0-FA4F5406A0C5 Q28828148-0D945428-753B-4460-9583-606D4702B677 Q30010211-5730C3CC-7F78-4B2D-91F1-29BA45E0694B Q30426385-228CDBF4-5C97-41EC-AE82-4325091F9192 Q30426938-7E93721F-810E-4576-9E10-DD5855AB2FF7 Q30434183-4E5982D2-D909-45C1-A278-2D859ED0EEB2 Q30479772-AD1805FF-E367-4E5B-9797-2AE11E1AE588 Q30626213-D887B44C-AAFA-4B4B-913A-8BA4A1F4FE2D Q33265885-AD7EA473-B653-4FCB-BE9A-0BA9A7803B9F Q33414472-089AFF26-C7FD-4827-AF65-82A448AEF44A Q33585305-5E6FB922-5152-4A33-80E0-1FD4BB60F091 Q33590390-29EE8F7A-93D3-4772-ADDF-3CB59711A75D Q33607045-F8D9C7A5-85E8-4F12-A8C0-119D7397AD7E Q33686844-608788D6-58CB-4EDF-AA91-BADBFCCDF350 Q33700795-57E70615-8A43-4B82-B56F-8B8675F5E717 Q33730717-DEDFBB54-51E5-4C70-8E17-3CB96781027E

P2860

Reciprocal activating interaction between natural killer cells and dendritic cells.

http://www.wikidata.org/entity/Q41992239

description

2002 nî lūn-bûn

@nan

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

2002年论文

@zh

2002年论文

@zh-cn

name

Reciprocal activating interaction between natural killer cells and dendritic cells.

@en

type

label

Reciprocal activating interaction between natural killer cells and dendritic cells.

@en

prefLabel

Reciprocal activating interaction between natural killer cells and dendritic cells.

@en

P1433

Q41992239-9F335FC2-7F74-4049-9E41-315CDDC95228

P1476

Q41992239-BC4ABEC5-05CB-482B-A551-5ABCFA8AAAEA

P2093

Q41992239-30B559FD-451A-4453-B1B6-7819F0210F71

Q41992239-4A121AA8-60B6-42FC-B2C4-024503391254

Q41992239-6A6C50E4-A771-4E4E-B860-884200765CA1

Q41992239-82A82CE9-733B-4095-82BF-354FC002EFED

Q41992239-8324C1BC-0C07-48ED-A188-69F8C7E8511B

Q41992239-CEDA1DDF-7CE3-4770-B96E-C9015407BE9A

P2860

Q41992239-1059B1F9-93B4-44C3-A400-58C4F3E05314

Q41992239-2421D22C-87A2-48F3-8C50-9479D5954A9C

Q41992239-29817369-8048-4871-B4CB-9963042C9ED3

Q41992239-2FEEA1B8-9668-48B9-A348-C313EB61C44D

Q41992239-4706C3C0-B5BD-486B-B754-B0ABFFC05B0D

Q41992239-55BEFA82-2745-45F8-A132-D190CBE9C33A

Q41992239-56EE8E59-7EAF-48E3-9F7D-4AB6BA356868

Q41992239-5A621BB7-6382-451B-BE52-E903E58B395A

Q41992239-5CA1E07C-9847-416D-BE59-EC47B782B304

Q41992239-60765374-0DA7-4BDE-BEAD-9B5DA14705F4

P304

Q41992239-A7E475E9-9C51-4696-BEE3-FE2C9BCAC3F3

P31

Q41992239-1CFA1C5E-9E88-472B-A340-49563FC8BD5F

P356

Q41992239-2D08BDB7-4F38-4701-B74E-96024F33A6EA

P407

Q41992239-98EC6216-D35E-44BB-9545-5BB672CC0DE2

P433

Q41992239-27D92B35-3A00-4FBC-ABDD-6D58F2000C6D

P478

Q41992239-B2817AB6-CB09-4E85-864C-1DC5F78EB2A1

P577

Q41992239-94EFFF37-9C08-41C1-BBC5-C91CFF0AFBC2

P5875

Q41992239-0A4D7BAA-035E-4238-9556-3969B45C94C5

P698

Q41992239-9FFCF4AF-9BCE-4A0D-BFB7-FB3A9789A473

P932

Q41992239-BE941EA5-9630-4FAB-B712-CB2EE0FFD307

P356

P1433

Journal of Experimental Medicine

P1476

Reciprocal activating interaction between natural killer cells and dendritic cells.

@en

P2093

Barbara Baldani-Guerra

http://www.w3.org/2001/XMLSchema#string

Carla Nisii

http://www.w3.org/2001/XMLSchema#string

Franca Gerosa

http://www.w3.org/2001/XMLSchema#string

Giorgio Trinchieri

http://www.w3.org/2001/XMLSchema#string

Giuseppe Carra

http://www.w3.org/2001/XMLSchema#string

Viviana Marchesini

http://www.w3.org/2001/XMLSchema#string

P2860

A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function

Immunobiology of dendritic cells

Biology of natural killer cells

The nature of the principal type 1 interferon-producing cells in human blood

Enhancement of human cord blood CD34+ cell-derived NK cell cytotoxicity by dendritic cells.

Consequences of cell death: exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells

Natural killer cells wear different hats: effector cells of innate resistance and regulatory cells of adaptive immunity and of hematopoiesis.

The role of natural killer cells in host-parasite interactions.

Targeting of human dendritic cells by autologous NK cells.

Human NK cells constitutively express membrane TNF-alpha (mTNFalpha) and present mTNFalpha-dependent cytotoxic activity.

P304

327-333

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1084/JEM.20010938

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

195

http://www.w3.org/2001/XMLSchema#string

P577

2002-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11532388

http://www.w3.org/2001/XMLSchema#string

P698

11828007

http://www.w3.org/2001/XMLSchema#string

P932

2193595

http://www.w3.org/2001/XMLSchema#string